Shares of dental products company Dentsply Sirona (NASDAQ:XRAY) rose 1.1% in the afternoon session after the U.S. Securities ...

BofA lowered the firm’s price target on Dentsply Sirona (XRAY) to $15 from $17 and keeps a Neutral rating on the shares. With data and checks ...

Dentsply Sirona (XRAY) on Tuesday said that the U.S. Securities and Exchange Commission has ended its investigation into the ...

ASP Isotopes is commencing an underwritten public offering. Shares fell 10% to $12.69 after the bell Tuesday. Dentsply Sirona said a Securities and Exchange Commission probe into its accounting ...

Now, in an SEC filing dated Oct. 14, Dentsply said the SEC concluded its investigation and doesn’t recommend any enforcement ...

Dentsply Sirona shares gained after the Securities and Exchange Commission concluded its investigation of the company. The stock rose 7% to $13.30 in after-hours trading Tuesday. Through the close, ...

In the last three months, 5 analysts have published ratings on Dentsply Sirona (NASDAQ: XRAY), offering a diverse range of perspectives from bullish to bearish. The table below provides a concise ...

CHARLOTTE, N.C., Oct. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and ...

This seamless integration of DS Core, Dentsply Sirona’s cloud-based platform, with Second Opinion®, Pearl’s chairside dental AI software, is aimed at enhancing 2D X-ray radiologic accuracy and patient ...

Dentsply Sirona Inc, a global leader in dental products and technologies with $3.67 billion in annual revenue, has seen its stock reach a 52-week low, closing at $12.14. According to InvestingPro ...

CHARLOTTE, N.C., Oct. 02, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Aldo M. Denti has been appointed Executive Vice ...